As of January 22, 2025, Cybin (CYBN) has a market cap of $0.20 billion USD. According to our data, Cybin is ranked No.7103 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.20 B |
13.49%
|
Dec 31, 2024 | $0.18 B |
-43.39%
|
Dec 29, 2023 | $0.31 B |
38.05%
|
Dec 30, 2022 | $0.23 B |
-75.25%
|
Dec 31, 2021 | $0.91 B |
-19.46%
|
Dec 31, 2020 | $1.13 B |
13.27%
|
Dec 31, 2019 | $1.00 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
COMPASS Pathways
CMPS
|
$0.34 B |
-0.000 M
|
UK
|
Mind Medicine
MNMD
|
$0.51 B |
0.000 M
|
USA
|
Atai Life Sciences
ATAI
|
$0.26 B |
0.000 M
|
Germany
|
GH Research
GHRS
|
$0.46 B |
0.000 M
|
Ireland
|
Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
USA
|
Neonode
NEON
|
$0.15 B |
-0.000 M
|
Sweden
|
Market Cap | = | CYBN Stock Price | * | CYBN Shares Outstanding |
= | $10.01 | * | 19.99 M | |
= | $0.20 B |